Bayerische Motoren Werke ADR (BMWYY)
29.20
+0.00 (0.00%)
OP · Last Trade: Sep 28th, 12:04 PM EDT
Detailed Quote
| Previous Close | 29.20 |
|---|---|
| Open | - |
| Bid | - |
| Ask | - |
| Day's Range | N/A - N/A |
| 52 Week Range | N/A - N/A |
| Volume | 0 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | - |
Chart
News & Press Releases
Lucid's progress has been slow over the past several years. While production has gained some momentum recently, it's not enough to offset the company's losses.
Via The Motley Fool · September 28, 2025
In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a growing consensus: patients, providers, and regulators all want sharper images with lower radiation exposure.
Via Investor Brand Network · September 26, 2025
Landmark Study Shows How Menopause Influences the Symptoms of Multiple Sclerosis
Groundbreaking research presented at the ECTRIMS 2025 conference held in Barcelona, Spain provides new insights into the ways in which menopause impacts the health implications and clinical manifestations in women who have multiple sclerosis. This study shows that changes in hormones influence the initial symptoms experienced by women with MS and also play a role in the comorbidities suffered by the affected individuals.
Via Investor Brand Network · September 26, 2025
German automaker BMW of North America LLC has issued a recall of over 196,355 units of its vehicles in the U.S. over a starter defect that can become a potential fire hazard.
Via Benzinga · September 26, 2025
September 25, 2025 – Tesla (NASDAQ: TSLA) shares experienced a notable decline today, trading lower amid broader market weakness and specific concerns stemming from a significant slump in its European sales performance. This downturn, which saw TSLA shares drop by over 3% to 4% throughout the day, trading around $424.54
Via MarketMinute · September 25, 2025
AmericanDreamAutoProtect Shares What Drivers Can Expect to Pay for Extended Car Warranties in 2025
When drivers think about extended car warranties, the first question that usually comes to mind is simple: How much does it cost?
Via AB Newswire · September 25, 2025
Feature Image: [Placeholder for an image of silver bars or a silver chart with an upward trend]
Delhi's bullion market witnessed a monumental event on Thursday, September 25, 2025, as silver prices surged to an unprecedented Rs 1.40 lakh per kilogram. This record-breaking rally, largely sustained since September 23,
Via MarketMinute · September 25, 2025
As of September 25, 2025, the financial markets are abuzz with anticipation surrounding silver, which appears to be on the verge of a monumental "historic breakout." Technical analysts are pointing to a rare and powerful 45-year "cup-and-handle" pattern on silver's long-term charts, a formation that, if confirmed, could unleash a
Via MarketMinute · September 25, 2025
Shares of automotive retailer Lithia Motors (NYSE:LAD)
fell 6.1% in the morning session after investor sentiment soured on the used-car retail sector as competitor CarMax reported weak second-quarter results that missed expectations.
Via StockStory · September 25, 2025
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Appoints Mark Guerin as Chief Financial Officer
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced the appointment of Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer to help guide the Company as its lead drug candidate, buntanetap, advances through late-stage trials. Guerin previously served as CFO of Onconova Therapeutics, now Traws Pharma (NASDAQ: TRAW), where he oversaw multiple financings and a merger that formed the new entity. His earlier roles include senior finance positions at Cardiokine, Barrier Therapeutics, and Coopers & Lybrand. Guerin said he is eager to support Annovis as it works to replicate buntanetap’s early success in registrational studies and deliver solutions for patients with Alzheimer’s and Parkinson’s disease.
Via Investor Brand Network · September 25, 2025
Researchers Find That Common Nutrient Could Supercharge the Immune Cells Fighting Cancer
A recently published study by a team at the University of Chicago suggests that a carotenoid called zeaxanthin, naturally occurring in plants like kale, spinach and orange peppers, and well known for its benefits in eye health, could also play a role in supercharging the immune system during the fight against cancer.
Via Investor Brand Network · September 25, 2025
As October approaches, all eyes in the financial world are fixated on Tesla (NASDAQ: TSLA), whose upcoming third-quarter 2025 earnings report is poised to be a pivotal moment for the electric vehicle (EV) giant. The report, expected around October 22nd, arrives at a critical juncture for the company, with market
Via MarketMinute · September 24, 2025
Soligenix Inc. (NASDAQ: SNGX) Strengthens Position in CTCL Treatment with HyBryte(TM) FLASH Results
Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported by results from its pivotal FLASH trial and its ongoing FLASH 2 confirmatory study. Together, the studies highlight not only the efficacy of synthetic hypericin activated by safe fluorescent light but also the company’s broader strategy to establish HyBryte as a new standard of care in a field where therapeutic innovation has lagged ( https://www.ibn.fm/G18Hp ). With statistically significant data already achieved and confirmatory enrollment well underway, Soligenix is taking important steps toward potential regulatory approvals Worldwide.
Via Investor Brand Network · September 24, 2025
HiLine Motors, a trusted name in luxury pre-owned vehicles across the Dallas–Fort Worth area, has officially opened the doors to its brand-new, state-of-the-art auto service and repair center . Conveniently located on its dealership lot at 4480 W Plano Parkway in Plano, Texas, the new facility is open to the public and welcomes all makes and models—luxury and non-luxury alike—including vehicles still under manufacturer warranty. This expansion adds a full suite of service options to HiLine's offerings, providing customers with one-stop access to high-quality auto sales, maintenance, and repair in one location.
Via Get News · September 24, 2025
BioMedNewsBreaks — Fifty 1 Labs, Inc. (OTC: FITY) Engages PCAOB Auditor to Support Planned OTCQB Uplist
Fifty 1 Labs (OTC: FITY), a Nevada-based holding company focused on AI-driven drug repurposing and functional medicine, announced it has signed a letter of engagement with a Public Company Accounting Oversight Board registered auditing firm to conduct audits of its 2024 and 2025 financial statements. The audits mark a key step in the company’s plan to uplist to the OTCQB Venture Market, which requires strict reporting and governance standards. CEO Paul Arora said the engagement underscores Fifty 1 Labs’ commitment to transparency and corporate governance, while laying the groundwork to strengthen investor confidence as it advances biotech and wellness initiatives.
Via Investor Brand Network · September 23, 2025
Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) CEO Featured in BMW Podcast Discussing Breakthrough Breast CT Imaging
A new episode of the BioMedWire Podcast shines a spotlight on Izotropic (CSE: IZO) (OTCQB: IZOZF) and its innovative approach to breast cancer imaging. Featuring IZO CEO Robert Thast, the podcast ( ibn.fm/JUWtD ) reveals how Izotropic’s proprietary Breast CT technology could transform early detection, improve patient outcomes and set the company on a trajectory toward commercial success in major healthcare markets. With both its groundbreaking science and its business vision on display, the conversation captures why Izotropic is gaining attention across the medical imaging sector.
Via Investor Brand Network · September 23, 2025
How Federal Policies are Making Health Care More Costly for Families
Most American families are very concerned about health care costs, and recent policy decisions at the federal level will increase the costs that families have to incur for health care. We discuss some of those policy decisions that are causing an uptick in the cost of health care .
Via Investor Brand Network · September 23, 2025
In a bold move that could fundamentally reshape the future of transportation and industry, Tesla (NASDAQ: TSLA) is aggressively pursuing a dual strategy centered on its ambitious Robotaxi service and the burgeoning capabilities of its Optimus humanoid robot. This integrated vision, championed by CEO Elon Musk, positions the electric vehicle
Via MarketMinute · September 22, 2025
Shares of carbonate fuel cell technology developer FuelCell Energy (NASDAQ:FCEL)
jumped 5.6% in the morning session after a raft of positive news across the hydrogen and fuel cell industry lifted investor sentiment for the sector.
Via StockStory · September 22, 2025
NVIDIA (NASDAQ: NVDA) continues to be the undisputed titan in the artificial intelligence arena, recently unveiling a dazzling Q2 fiscal year 2026 earnings report that underscored its foundational role in the global AI revolution. The company reported a remarkable 56% year-over-year surge in its Data Center revenue, propelling overall revenue
Via MarketMinute · September 22, 2025
Tesla's current trajectory reveals a company strategically recalibrating its future, shifting its emphasis from solely an electric vehicle (EV) manufacturer to a diversified technology and energy powerhouse. This pivotal move involves aggressive expansion into artificial intelligence (AI), particularly through its Optimus humanoid robot and Full Self-Driving (FSD) initiatives, alongside a
Via MarketMinute · September 22, 2025
Unity's strategic pivot to AI-driven growth is fueling record cash flow and expanding its platform beyond gaming into high-value industrial markets.
Via MarketBeat · September 22, 2025
The new shop was built with both performance and comfort in mind. Highlights include a customer breezeway for convenient drop-offs and pickups, in-ground lifts for precision service, Italian flooring throughout the workshop, and a modern customer waiting area that reflects the company’s commitment to providing a premium experience. Every detail, from the layout of the service bays to the polished finishes, is designed around delivering white glove service that matches the level of care BMW drivers expect.
Via AB Newswire · September 19, 2025
Oncotelic Therapeutics Inc. (OTLC): Leadership and Innovation Drive Late-Stage Biotech Momentum
The biotechnology sector is defined by its ability to pair scientific innovation with leadership that can translate discoveries into approved therapies. This is particularly critical in oncology, where late-stage candidates must navigate complex regulatory pathways and demonstrate real clinical impact in indications with limited treatment options. Companies that combine robust intellectual property with seasoned leadership are positioned to accelerate value creation for patients and investors alike.
Via Investor Brand Network · September 19, 2025
UCLA Researchers Receive $2M Grant to Study MRI-Guided Cancer Radiation Therapy
A grant of $2 million has been awarded to UCLA Health by a for-profit company, ViewRay Systems. The purpose of this grant is to enable the university to accelerate its research efforts in finding ways in which MRI-guided radiation therapy can be leveraged to provide targeted treatment to cancer patients.
Via Investor Brand Network · September 19, 2025